drugset / Trial / NCT05607017

Losartan in Prevention of Radiation-Induced Heart Failure

NCT05607017

Phase 0 Completed 5 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to see if losartan affects the chances of developing radiation-induced heart failure in patients who are receiving radiation therapy as part of standard of care treatment for breast cancer. The interventions involved in this study are: * Losartan * Radiation Therapy (standard of care)

Timeline

Start
2023-09-13
Primary completion
2025-10-07
Completion
2025-10-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified Oral